Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation | Zendy

Adam Bryant | Zendy; Harold Atkins | Zendy; C. Elizabeth Pringle | Zendy; David Allan | Zendy; Grizel Anstee | Zendy; Isabelle BenceBruckler | Zendy; Linda Hamelin | Zendy; Michael Hodgins | Zendy; Harry S. Hopkins | Zendy; Lothar Huebsch | Zendy; Sheryl McDiarmid | Zendy; Mitchell Sabloff | Zendy; Dawn Sheppard | Zendy; Jason Tay | Zendy; Christopher Bredeson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation

Author(s) -

Adam Bryant,

Harold Atkins,

C. Elizabeth Pringle,

David Allan,

Grizel Anstee,

Isabelle BenceBruckler,

Linda Hamelin,

Michael Hodgins,

Harry S. Hopkins,

Lothar Huebsch,

Sheryl McDiarmid,

Mitchell Sabloff,

Dawn Sheppard,

Jason Tay,

Christopher Bredeson

Publication year - 2016

Publication title -

jama neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.298

H-Index - 231

eISSN - 2168-6157

pISSN - 2168-6149

DOI - 10.1001/jamaneurol.2016.0113

Subject(s) - myasthenia gravis , hematopoietic stem cell transplantation , transplantation , stem cell , haematopoiesis , medicine , immunology , biology , surgery , microbiology and biotechnology

Some patients with myasthenia gravis (MG) do not respond to conventional treatment and have severe or life-threatening symptoms. Alternate and emerging therapies have not yet proved consistently or durably effective. Autologous hematopoietic stem cell transplant (HSCT) has been effective in treating other severe autoimmune neurologic conditions and may have similar application in MG.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research